Investigating mechanisms of cardiotoxicity
A compound may affect cardiac electrical activity, calcium handling and mechanical function at the same time. Starting with the model and research question, we combine functional endpoints to characterize abnormal phenotypes and their concentration and time dependence, providing evidence for mechanism studies and comparisons between candidates.
Research models
Studies can use primary cardiomyocytes, iPSC-derived cardiomyocytes, cardiac organoids and cardiac-like tissues. Model origin, maturation in culture, tissue thickness and accessibility for measurement influence the experimental approach and interpretation.
From functional phenotypes to mechanistic hypotheses
| Area of observation | Research scope |
|---|---|
| Electrical activity and rhythm | Examine repolarization and rhythm changes using action potential recordings, voltage imaging or field potentials. |
| Calcium handling | Analyze calcium transient amplitude, kinetics, abnormal events and regional consistency. |
| Contraction and relaxation | Use motion-based or mechanical measurements to assess mechanical function and its relationship to electrical and calcium signals. |
| Culture condition and persistent effects | In suitable systems, combine baseline impedance, extended exposure and independent measurements of cell condition to distinguish functional responses from changes in cell state. |
Functional measurements can support mechanistic hypotheses, but do not by themselves establish abnormal trafficking of a particular ion channel, a specific molecular target or structural damage. Ion channel assays, biochemical studies or other targeted experiments are required to build further evidence. Optical voltage signals do not directly measure absolute membrane potential, and beating-related impedance does not directly measure contractile force.
Study design
- Include appropriate vehicle, positive or reference controls and document baseline function.
- Define concentration ranges, exposure durations and, where necessary, recovery observations according to the research objective.
- Use comparable sample conditions and analysis criteria across functional endpoints.
- Interpret findings in the context of cell condition, signal quality and model limitations.
Project design and deliverables
The model, treatment concentrations, exposure times, control conditions and replicate design are agreed according to the study objectives. Results are analyzed alongside sample-condition and quality-control information.
- Functional parameters and concentration-response and time-response analyses.
- Integrated comparison across functional processes, with descriptions of abnormal events.
- Mechanistic hypotheses, alternative explanations and experimental directions for further validation.
In vitro results support research decisions; they do not independently determine clinical cardiovascular risk.
